Abstract:During the last few years, for therapeutic purposes in oncology, considerable attention has been focused on a method called magnetic fluid hyperthermia (MFH) based on local heating of tumor cells. In this paper, an innovative, promising nanomaterial, M48 composed of iron oxide-based phases has been tested. M48 shows self-regulating temperature due to the observable second order magnetic phase transition from ferromagnetic to paramagnetic state. A specific hydrophilic coating based on both citrate ions and gluc… Show more
“…Centrifugation was used to extract nanosized particles (<200 nm). This process further improves the one previously used [ 6 ]: detailed processing parameters are provided courtesy of MBN Nanomaterialia S.p.A.…”
Section: Methodsmentioning
confidence: 95%
“…The challenges of MFH are the need to deliver a large quantity of MNPs to the tumor tissue, and the risk of overheating healthy peritumoral tissue [ 6 ]. In currently applied preclinical and clinical protocols, nanoparticles are injected directly into the tumor tissue.…”
Section: Introductionmentioning
confidence: 99%
“…The risk of overheating healthy peritumoral tissue has been previously addressed by us and by other groups [ 6 , 8 ] using self-regulating temperature MNPs [ 9 ]. Gerosa et al report an extensive investigation of a self-regulating temperature nanomaterial, synthesized by MBN Nanomaterialia S.p.A. (Treviso, Italy).…”
Section: Introductionmentioning
confidence: 99%
“…Above the T C , magnetization is negligible and the heating effect of the AMF ceases. Interestingly, above Tc, a sharp decrease in transverse MRI relaxivity occurs, meaning that the MNP is suitable for use as a temperature-sensitive contrast agent [ 6 ]. In principle, these properties are particularly useful when the nanomaterial is integrated into biological matrices, making it possible to limit the maximum temperature and, at the same time, monitor temperature changes by means of imaging.…”
Section: Introductionmentioning
confidence: 99%
“…M55, the MNP studied in the present paper, is obtained from previously described M48 material [ 6 ], by implementing an additional purification step in the synthesis process so as to remove potential paramagnetic by-products from the liquid suspension. In investigating this class of materials, we have already considered their properties as theranostic agents for MPI, in view of the foreseen application of MPI in MFH [ 4 , 7 ].…”
This paper reports a comprehensive investigation of a magnetic nanoparticle (MNP), named M55, which belongs to a class of innovative doped ferrite nanomaterials, characterized by a self-limiting temperature. M55 is obtained from M48, an MNP previously described by our group, by implementing an additional purification step in the synthesis. M55, after citrate and glucose coating, is named G-M55. The present study aimed to demonstrate the properties of G-M55 as a diagnostic contrast agent for MRI and magnetic particle imaging (MPI), and as an antitumoral agent in magnetic fluid hyperthermia (MFH). Similar specific absorption rate values were obtained by standard MFH and by an MPI apparatus. This result is of interest in relation to the application of localized MFH by MPI apparatus. We demonstrated the biocompatibility of G-M55 in a triple-negative human breast cancer line (MDA-MB-231), and its efficacy as an MFH agent in the same cell line. We also demonstrated the efficacy of MFH treatment with G-M55 in an experimental model of breast cancer. Overall, our results pave the way for the clinical application of G-M55 as an MFH agent in breast cancer therapy, allowing not only efficient treatment by both standard MFH apparatus and MPI but also temperature monitoring.
“…Centrifugation was used to extract nanosized particles (<200 nm). This process further improves the one previously used [ 6 ]: detailed processing parameters are provided courtesy of MBN Nanomaterialia S.p.A.…”
Section: Methodsmentioning
confidence: 95%
“…The challenges of MFH are the need to deliver a large quantity of MNPs to the tumor tissue, and the risk of overheating healthy peritumoral tissue [ 6 ]. In currently applied preclinical and clinical protocols, nanoparticles are injected directly into the tumor tissue.…”
Section: Introductionmentioning
confidence: 99%
“…The risk of overheating healthy peritumoral tissue has been previously addressed by us and by other groups [ 6 , 8 ] using self-regulating temperature MNPs [ 9 ]. Gerosa et al report an extensive investigation of a self-regulating temperature nanomaterial, synthesized by MBN Nanomaterialia S.p.A. (Treviso, Italy).…”
Section: Introductionmentioning
confidence: 99%
“…Above the T C , magnetization is negligible and the heating effect of the AMF ceases. Interestingly, above Tc, a sharp decrease in transverse MRI relaxivity occurs, meaning that the MNP is suitable for use as a temperature-sensitive contrast agent [ 6 ]. In principle, these properties are particularly useful when the nanomaterial is integrated into biological matrices, making it possible to limit the maximum temperature and, at the same time, monitor temperature changes by means of imaging.…”
Section: Introductionmentioning
confidence: 99%
“…M55, the MNP studied in the present paper, is obtained from previously described M48 material [ 6 ], by implementing an additional purification step in the synthesis process so as to remove potential paramagnetic by-products from the liquid suspension. In investigating this class of materials, we have already considered their properties as theranostic agents for MPI, in view of the foreseen application of MPI in MFH [ 4 , 7 ].…”
This paper reports a comprehensive investigation of a magnetic nanoparticle (MNP), named M55, which belongs to a class of innovative doped ferrite nanomaterials, characterized by a self-limiting temperature. M55 is obtained from M48, an MNP previously described by our group, by implementing an additional purification step in the synthesis. M55, after citrate and glucose coating, is named G-M55. The present study aimed to demonstrate the properties of G-M55 as a diagnostic contrast agent for MRI and magnetic particle imaging (MPI), and as an antitumoral agent in magnetic fluid hyperthermia (MFH). Similar specific absorption rate values were obtained by standard MFH and by an MPI apparatus. This result is of interest in relation to the application of localized MFH by MPI apparatus. We demonstrated the biocompatibility of G-M55 in a triple-negative human breast cancer line (MDA-MB-231), and its efficacy as an MFH agent in the same cell line. We also demonstrated the efficacy of MFH treatment with G-M55 in an experimental model of breast cancer. Overall, our results pave the way for the clinical application of G-M55 as an MFH agent in breast cancer therapy, allowing not only efficient treatment by both standard MFH apparatus and MPI but also temperature monitoring.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.